ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2019

Efficacy and Safety of Switching to Teneligliptin in Patients with Type 2 Diabetes Inadequately Controlled with Dipeptidyl Peptidase-4 Inhibitors: A 12-Week Interim Report.

Hae Jin Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.